DiaMedica Therapeutics Inc. Uncategorized Contracts & Agreements
5 Contracts & Agreements
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2024)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2021)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 23, 2020)
- Specimen Certificate representing common shares of DiaMedica Therapeutics Inc (Filed With SEC on November 19, 2018)
- GPEx - Derived Cell Line Sale Agreement between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC dated February 2, 2012 (Filed With SEC on November 9, 2018)
